Search Results - "Moore, Angela Y."

Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris by Moore, Angela Y., Hurley, Kara

Get full text

Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity by Grada, Ayman, Del Rosso, James Q, Moore, Angela Y, Stein Gold, Linda, Harper, Julie, Damiani, Giovanni, Shaw, Katharina, Obagi, Sabine, Salem, Raidah J, Tanaka, S Ken, Bunick, Christopher G

“…Vestibular side effects such as dizziness and vertigo can be a limitation for some antibiotics commonly used to treat acne, rosacea, and other dermatology…”
Get full text

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials by Lebwohl, Mark G, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Draelos, Zoe D, Gooderham, Melinda J, Papp, Kim A, Bagel, Jerry, Bhatia, Neal, Del Rosso, James Q, Ferris, Laura K, Green, Lawrence J, Hebert, Adelaide A, Jones, Terry, Kempers, Steven E, Pariser, David M, Yamauchi, Paul S, Zirwas, Matthew, Albrecht, Lorne, Devani, Alim R, Lomaga, Mark, Feng, Amy, Snyder, Scott, Burnett, Patrick, Higham, Robert C, Berk, David R

“…IMPORTANCE: Once-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of…”
Get full text

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial by Blauvelt, Andrew, Draelos, Zoe D., Stein Gold, Linda, Alonso-Llamazares, Javier, Bhatia, Neal, DuBois, Janet, Forman, Seth B., Gooderham, Melinda, Green, Lawrence, Guenthner, Scott T., Hebert, Adelaide A., Lain, Edward, Moore, Angela Y., Papp, Kim A., Zirwas, Matthew, Kato, Saori, Snyder, Scott, Krupa, David, Burnett, Patrick, Berk, David R., Chu, David H.

“…The topical phosphodiesterase 4 inhibitor roflumilast has been studied in several dermatologic conditions. Roflumilast foam 0.3% is being investigated as a…”
Get full text

Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management by Daniele, Stefano G., Kim, Sa Rang, Grada, Ayman, Moore, Angela Y., Suozzi, Kathleen C., Bunick, Christopher G.

“…Acne vulgaris is one of the most common skin disorders worldwide. It typically affects skin areas with a high density of sebaceous glands such as the face,…”
Get full text

Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation by Alexis, Andrew, Del Rosso, James Q., Forman, Seth, Martorell, Antonio, Browning, John, Laquer, Vivian, Desai, Seemal R., York, Jean Philippe, Chavda, Rajeev, Dhawan, Sunil, Moore, Angela Y., Stein‐Gold, Linda

“…Background Acne‐induced hyperpigmentation (AIH) may accompany acne vulgaris (AV) inflammation in all skin phototypes. Trifarotene has shown depigmenting…”
Get full text

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial by Zirwas, Matthew J, Draelos, Zoe D, DuBois, Janet, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Alonso-Llamazares, Javier, Bukhalo, Michael, Bruce, Suzanne, Eads, Kimmie, Green, Lawrence J, Guenthner, Scott T, Ferris, Laura K, Forman, Seth B, Kempers, Steven E, Lain, Edward, Lynde, Charles W, Pariser, David M, Toth, Darryl P, Yamauchi, Paul S, Higham, Robert C, Krupa, David, Burnett, Patrick, Berk, David R

“…Current topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety. To assess safety and efficacy of roflumilast foam, 0.3%, in…”
Get more information

Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy by Grada, Ayman, Del Rosso, James Q., Graber, Emmy, Bunick, Christopher G., Stein Gold, Linda, Moore, Angela Y., Baldwin, Hilary, Obagi, Zaidal, Damiani, Giovanni, Carrothers, Timothy, McNamee, Brian, Hanze, Eva

“…Tetracycline‐class antibiotics are frequently prescribed by dermatologists, commonly for acne vulgaris. Gastrointestinal absorption of first and…”
Get full text

Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature by Moore, Angela Y, Richardson, Blakely S

“…Psoriasis is a chronic T-cell-mediated inflammatory disease that primarily affects the skin and joints. Patients with moderate to severe psoriasis constitute…”
Get full text

Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices by Zeitouni, Nathalie C, Bhatia, Neal, Ceilley, Roger I, Cohen, Joel L, Del Rosso, James Q, Moore, Angela Y, Munavalli, Gilly, Pariser, David M, Schlesinger, Todd, Siegel, Daniel M, Willey, Andrea, Goldman, Mitchel P

“…Photodynamic therapy (PDT) can be an effective treatment for actinic keratosis (AK) as well as selected non-melanoma skin cancers (NMSCs), such as Bowen's…”
Get full text

Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome by Lamba, Anu R., Moore, Angela Y., Moore, Todd, Rhees, Jennifer, Arnold, Mildred A., Richard Boland, C.

“…A subset of individuals with Lynch syndrome (LS) has a variant called Muir-Torre syndrome (MTS) where patients develop multiple sebaceous neoplasms. Absence of…”
Get full text

Tu1682 Defective DNA Mismatch Repair Activity Is Common in Sporadic Sebaceous Neoplasms, and an Ineffective Approach to Screen for Lynch Syndrome by Lamba, Anu R, Moore, Angela Y, Rhees, Jennifer, Arnold, Mildred (Millie) A, Boland, C. Richard

Get full text

388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus by Blauvelt, Andrew, Draelos, Zoe D, Gooderham, Melinda , Lain, Edward, Moore, Angela Y, Papp, Kim A, Zirwas, Matthew, Krupa, David, Burnett, Patrick, Berk, David R, Chu, David H

“…Abstract Itch is a major complaint among patients with seborrheic dermatitis (SD). Roflumilast is a selective, nonsteroidal, highly potent phosphodiesterase-4…”
Get full text

Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial by Bagel, Jerry, Gold, Linda Stein, Del Rosso, James, Johnson, Sandy, Yamauchi, Paul, Brown, Philip M., Bhatia, Neal, Moore, Angela Yen, Tallman, Anna M.

“…Tapinarof cream 1% once daily demonstrated significant efficacy versus vehicle and was well tolerated in two 12-week, phase 3 pivotal trials in adults with…”
Get full text

27535 Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: 104-week data from a phase 2 study by Harris, John E., Pandya, Amit G., Lebwohl, Mark, Grimes, Pearl, Gottlieb, Alice B., Sofen, Howard L., Moore, Angela Y., Butler, Kathleen, Kuo, Fiona, Sun, Kang, Rosmarin, David

Get full text

33467 Long-term safety and efficacy of roflumilast cream 0.3% in patients with chronic plaque psoriasis: Interim results from a 24-week, phase 3 open-label study by Papp, Kim A., Adam, David N., Gooderham, Melinda J., Green, Lawrence J., Lebwohl, Mark, Moore, Angela Y., Pariser, David M., Feng, Amy, Higham, Robert C., Burnett, Patrick, Berk, David R.

Get full text

Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus by Blauvelt, Andrew, Draelos, Zoe D., Gooderham, Melinda, Lain, Edward, Moore, Angela Y., Papp, Kim A., Zirwas, Matthew, Krupa, David, Burnett, Patrick, Berk, David R., Chu, David H.

Get full text

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years by Harris, John E., Pandya, Amit G., Lebwohl, Mark, Hamzavi, Iltefat H., Grimes, Pearl, Gottlieb, Alice B., Sofen, Howard L., Moore, Angela Y., Wang, Mingyue, Kornacki, Deanna, Butler, Kathleen, Rosmarin, David

Get full text

Patient Satisfaction with Tapinarof Cream 1% Once Daily for Plaque Psoriasis in a Long-Term Extension Trial by Bagel, Jerry, Stein Gold, Linda, Del Rosso, James, Bhatia, Neal, Johnson, Sandy, Yamauchi, Paul, Moore, Angela, Tallman, Anna

“…N/A…”
Get full text

Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris by Moore, Angela Y, Hurley, Kara

Get full text